By using HLA class I pentamers, it was shown that CD8+ T cell responses to EBV lytic antigens peaked during active disease and are lower during the inactive phases of MS, demonstrating that changes in the immune response to EBV are associated with the different phases of MS [47]. This evidence concerns the gene CD8A and myeloid sarcoma.